DWTX
DWTX
NASDAQ · Biotechnology

Dogwood Therapeutics Inc

$1.98
-0.10 (-4.81%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +1,015.2% upside
Low Target $13.69
Average Target $22.08
High Target $22.84
Current Price $1.98
Current
$1.98
Target
$22.08
$13.69 $22.08 avg $22.84
Scenario Analysis
Bear Case
$13.69
591.4%
Low target
Base Case
$22.08
+1,015.2%
Avg target
Bull Case
$22.84
+1,053.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$9.50
-79.2% from high
52-Week Low
$2.07
+-4.3% from low
Target vs 52W High
$22.08
+132.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.9%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +157.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.5%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.0%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.5%